CDH1 and inflammatory breast carcinoma: Other subtypes include invasive lobular carcinoma (ILC), characterized by a diffuse growth pattern due to loss of E-cadherin expression [56], and inflammatory breast cancer (IBC), an aggressive variant in which dermal lymphatics are obstructed by neoplastic emboli, leading to erythema, peau d’orange and rapid progression [57].